Neurorehabilitation Research

KEY FINDING: Upper limb rehabilitation robots show significant benefits in upper limb recovery, strength, motor control, and activities of daily living compared to traditional therapeutic approaches.

KEY FINDING: Non-invasive neurorehabilitation modalities could be prescribed in PNI, considering the synergetic power of FES and locomotor training as one of the best therapeutic approaches to obtain faster recovery of sensory–motor functions.

KEY FINDING: The use of MI was stated as effective in 19/22, and uncertain in the remnant studies.

KEY FINDING: Intrathecal baclofen injection significantly impacted spasticity, reducing the Ashworth Scale Score in both upper and lower limbs.

KEY FINDING: The experimental treatment involving HA showed an improvement in all patients' test scores in the experimental group, particularly regarding cognitive functions, mood disorders, activities of daily living, and quality of life.

KEY FINDING: The IMU-based system showed excellent agreement with the optical tracking system in individuals with SCI (ICC > 0.98) and good agreement in controls (ICC > 0.82).

KEY FINDING: Factors influencing acceptance and adaptation of ABT across healthcare settings in Canada, including identity, knowledge, and health system-related issues, were identified.

KEY FINDING: A general protocol of 60-minute sessions, three times a week, for nine weeks (27 sessions total) is a good starting point.

KEY FINDING: Initial BWS levels varied significantly across studies and diagnoses, with the highest levels used for individuals with MS and the lowest for those with TBI.

KEY FINDING: In animal studies, pairing VNS with rehabilitation therapy consistently improved motor outcomes compared to controls across stroke, TBI, and SCI models.